Stifel Financial’s AbCellera Biologics ABCL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$295K	Sell	84,544 -625	-0.7%	-$2.25K	﹤0.01%	3195
2025 Q4	$291K	Sell	85,169 -17,609	-17%	-$78.6K	﹤0.01%	3182
2025 Q3	$517K	Sell	102,778 -9,465	-8%	-$41.7K	﹤0.01%	2791
2025 Q2	$385K	Buy	112,243 +44,579	+66%	+$111K	﹤0.01%	2913
2025 Q1	$151K	Sell	67,664 -3,850	-5%	-$11K	﹤0.01%	3234
2024 Q4	$210K	Sell	71,514 -3,300	-4%	-$9.19K	﹤0.01%	3148
2024 Q3	$195K	Sell	74,814 -27,563	-27%	-$76.4K	﹤0.01%	3148
2024 Q2	$303K	Sell	102,377 -6,900	-6%	-$26.1K	﹤0.01%	2913
2024 Q1	$495K	Sell	109,277 -868	-0.8%	-$4.43K	﹤0.01%	2614
2023 Q4	$629K	Buy	110,145 +45,522	+70%	+$211K	﹤0.01%	2441
2023 Q3	$297K	Sell	64,623 -3,190	-5%	-$19.4K	﹤0.01%	2795
2023 Q2	$438K	Sell	67,813 -4,809	-7%	-$32.8K	﹤0.01%	2598
2023 Q1	$548K	Sell	72,622 -1,961	-3%	-$17.8K	﹤0.01%	2465
2022 Q4	$756K	Buy	74,583 +326	+0.4%	+$3.77K	﹤0.01%	2212
2022 Q3	$734K	Buy	74,257 +12,482	+20%	+$137K	﹤0.01%	2178
2022 Q2	$658K	Buy	61,775 +22,450	+57%	+$190K	﹤0.01%	2298
2022 Q1	$383K	Buy	39,325 +504	+1%	+$4.77K	﹤0.01%	2728
2021 Q4	$555K	Sell	38,821 -31,699	-45%	-$481K	﹤0.01%	2538
2021 Q3	$1.41M	Buy	70,520 +48,515	+220%	+$858K	﹤0.01%	1822
2021 Q2	$484K	Buy	22,005 +14,736	+203%	+$406K	﹤0.01%	2604
2021 Q1	$247K	Buy	+7,269	New	+$290K	﹤0.01%	2903